BiologicalDrug
BCG Vaccine clinical trials
Also written BCG.
- studies test it
- 109
- open now
- 17
- in phase 3
- 29
- first study started
- 1995
Keep track of what changes. Save the BCG Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
- BCG
- 43
Studies by the year they started
108 studies that test it; most in 2020 (12)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1997 | 1 |
| 1999 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 12 |
| 2021 | 10 |
| 2022 | 5 |
| 2023 | 11 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 25
- Phase 2
- 36
- Phase 3
- 29
- Phase 4
- 19
- No phase
- 13
What it is tested for
Each study’s main condition, where its own words name it.
- COVID-19
- 10
Who runs them
Industry 21 · Other 88
University of Oxford (9) · Bandim Health Project (7) · Massachusetts General Hospital (6) · Radboud University Medical Center (5) · Memorial Sloan Kettering Cancer Center (4) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (4) · ImmunityBio, Inc. (4) · Murdoch Childrens Research Institute (3)
Often tested with
Tested in the same studies.
Gemcitabine (7) · Nogapendekin alfa inbakicept (4) · Docetaxel (2) · Durvalumab (2) · Pembrolizumab (2) · Sasanlimab (1) · Disitamab vedotin (1) · Tremelimumab (1)
Studies
Open first, then newest update. How each study uses BCG Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 109
- A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)RecruitingPhase 2Merck Sharp & Dohme LLCNCT06833073Written as BCG
- Antibiotics and Vaccine Immune Responses StudyRecruitingPhase 4South Australian Health and Medical Research InstituteNCT06148025Written as BCG vaccine
- A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBCRecruitingPhase 3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT07726992Written as SHR-1501+BCG
- Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)RecruitingPhase 3Verity Pharmaceuticals Inc.NCT05037279Written as Bacillus Calmette-Guerin: Strain Russian BCG-I
- Evaluating the Safety and Immunogenicity of MTBVACRecruitingPhase 2HIV Vaccine Trials NetworkNCT05947890Written as BCG
- Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNot yet recruitingPhase 2ImmunityBio, Inc.NCT06829823Written as N-803 and BCG
- A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder CancerRecruitingPhase 1/2Suzhou Forlong Biotechnology Co., LtdNCT07122414Written as FL115+BCG
- A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.Not yet recruitingPhase 1/2Queen's UniversityNCT07064863Written as Gemcitabine + BCG
- BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in AfricaEnrolling by invitationPhase 4Bandim Health ProjectNCT07005726Written as BCG Vaccine
- Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?Enrolling by invitationEarly Phase 1Tamir Ben-HurNCT06078891Written as BCG vaccine
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBCRecruitingPhase 1Jiangsu Simcere Pharmaceutical Co., Ltd.NCT06186414Written as SIM0237 and BCG
- Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized StudyRecruitingNot applicableAl-Azhar UniversityNCT05626101Written as BCG
- Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)RecruitingPhase 3Chengdu CoenBiotech Co., LtdNCT06241755Written as BCG for Therapeutic Use
- Measles and BCG Vaccines for Mother and ChildRecruitingPhase 4Bandim Health ProjectNCT04899765Written as BCG vaccine
- A Controlled Human Infection Model (CHIM) With Intradermal BCG in MalawiNot yet recruitingNot applicableLiverpool School of Tropical MedicineNCT06178666Written as BCG
- Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular VolumeNot yet recruitingPhase 4Assiut UniversityNCT05701332Written as Bacillus Calmette Guerin
- Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without NephroureterectomyNot yet recruitingPhase 2Shaheen AlaneeNCT03345134Written as MK-3475 and BCG
- A Study of Sasanlimab in People With Non-muscle Invasive Bladder CancerActive, not recruitingPhase 3PfizerNCT04165317Written as Bacillus Calmette-Guerin
- Intravesical BCG vs GEMDOCE in NMIBCActive, not recruitingPhase 3ECOG-ACRIN Cancer Research GroupNCT05538663Written as Bacillus Calmette Guerin
- Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South AfricaWithdrawnPhase 1/2International Maternal Pediatric Adolescent AIDS Clinical Trials GroupNCT05539989Written as BCG Vaccine
See all 109 studies that test BCG Vaccine →
Given in every arm · 19 — BCG Vaccine is usual care beside what is tested
- ID93/GLA-SE Vaccination + BCG ChallengeRecruitingNot applicableUniversity of OxfordNCT06670755Written as BCG Danish
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerRecruitingPhase 1PfizerNCT07206225Written as BCG
- A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBCRecruitingPhase 3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT07424287Written as BCG for Injection
- Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)Active, not recruitingPhase 3Merck Sharp & Dohme LLCNCT03711032Written as BCG
- Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder CancerActive, not recruitingPhase 3AstraZenecaNCT03528694Written as Bacillus Calmette-Guerin (BCG)
- First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10bActive, not recruitingPhase 1Statens Serum InstitutNCT06050356Written as BCG
- Phase I Open Label BCG Clinical Trial Assessing TB Drugs and VaccinesCompletedPhase 1Fred Hutchinson Cancer CenterNCT05592223Written as BCG Vaccine USP
- A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)TerminatedPhase 3Bristol-Myers SquibbNCT04149574Written as Bacillus Calmette-Guérin (BCG)
- Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer PatientsActive, not recruitingPhase 3UNICANCERNCT03799835Written as BCG
- BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerTerminatedPhase 3NCIC Clinical Trials GroupNCT00352079Written as BCG vaccine
- Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder CancerActive, not recruitingPhase 3University of SydneyNCT02948543Written as Bacillus of Calmette-Guerin (BCG)
- Coadministration of GA2 Sporozoites With AdjuvantsStatus unknownEarly Phase 1Leiden University Medical CenterNCT05468606Written as BCG
- Propranolol Adjuvant Treatment of Bladder CancerStatus unknownPhase 2Central South UniversityNCT04493489Written as BCG
- Oral Lenalidomide and Intravesical BCG for Therapy of Bladder CancerCompletedPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT01373294Written as Bacille Calmette-Guerrin (BCG)
- Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder CarcinomaCompletedPhase 1Anchiano Therapeutics Israel Ltd.NCT01878188Written as BCG Vaccine
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African InfantsCompletedPhase 2GlaxoSmithKlineNCT01231503Written as BCG
- Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side EffectsCompletedPhase 2University of Rome Tor VergataNCT02207608Written as BCG (Immucist®)
- A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402CompletedPhase 1AerasNCT02375256Written as BCG (1-8 x105 cfu ID)
- Vaccine Therapy in Treating Patients With Stage D0 Prostate CancerStatus unknownPhase 2Kael-GemVax Co., Ltd.NCT00514072Written as BCG vaccine
As the comparator · 19 — what is tested is compared with BCG Vaccine
- The Role of Definitive Radiotherapy in Non Muscle Invasive Bladder CancerNot yet recruitingNot applicableAssiut UniversityNCT07873333Written as BCG
- Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan AfricaRecruitingPhase 3Biofabri, S.LNCT04975178Written as BCG
- Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder CancerRecruitingPhase 3Turku University HospitalNCT03664869Written as BCG instillation therapy
- Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African NeonatesCompletedPhase 2Biofabri, S.LNCT03536117Written as BCG
- MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South AfricaCompletedPhase 1/2International AIDS Vaccine InitiativeNCT02933281Written as BCG
- Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of BladderCompletedPhase 2Cadila PharnmaceuticalsNCT00694915Written as BCG (Bacillus Calmette-Guerin)
- Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy AdolescentsCompletedPhase 1AerasNCT02378207Written as BCG
- Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy AdolescentsCompletedPhase 2AerasNCT02075203Written as Bacillus Calmette-Guérin (BCG)
- Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in AdultsCompletedPhase 1/2Biofabri, S.LNCT02729571Written as BCG
- Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South AfricaCompletedPhase 2Serum Institute of India Pvt. Ltd.NCT02391415Written as BCG
- Phase I Trial of DAR-901CompletedPhase 1Dartmouth-Hitchcock Medical CenterNCT02063555Written as BCG
- SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study IWithdrawnPhase 3Medical Enterprises Europe B.V.NCT02254915Written as Bacillus Calmette-Guérin
- Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerTerminatedPhase 3Medical Enterprises Europe B.V.NCT00384891Written as Bacillus Calmette-Guérin
- First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBCWithdrawnPhase 3Bioniche Life Sciences Inc.NCT01284205Written as Bacillus Calmette-Guerin
- Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South AfricaCompletedPhase 2Vakzine Projekt Management GmbHNCT01479972Written as BCG
- Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder CancerCompletedPhase 3University of Rome Tor VergataNCT01442519Written as bacillus Calmette-Guerin
- Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)Status unknownPhase 3Urological Oncology Council of Northern TokyoNCT01082510Written as Bacille Calmette-Guerin
- Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male VolunteersCompletedPhase 1Vakzine Projekt Management GmbHNCT00749034Written as BCG
- Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder CancerCompletedPhase 1/2University Of PerugiaNCT00696579Written as BCG
Codes
What other systems call BCG Vaccine · ClinicalTrials.gg INT007047
- MeSH (NLM) D001500BCG VaccineConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 8VJE55B0VGBACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAINConfirmed FDA, Wikidata
- Wikidata Q798309BCG vaccineConfirmed FDA, Wikidata
- DrugBank DB12768One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001500 | BCG Vaccine | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 8VJE55B0VG | BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN | Confirmed FDA, Wikidata |
| Wikidata | Q798309 | BCG vaccine | Confirmed FDA, Wikidata |
| DrugBank | DB12768 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.